- Home
- RQI vs CNTA Comparison
RQI vs CNTA Comparison
Compare RQI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RQI
- CNTA
- Stock Information
- Founded
- RQI 2002
- CNTA 2020
- Country
- RQI United States
- CNTA United Kingdom
- Employees
- RQI N/A
- CNTA N/A
- Industry
- RQI Trusts Except Educational Religious and Charitable
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- RQI Finance
- CNTA Health Care
- Exchange
- RQI Nasdaq
- CNTA Nasdaq
- Market Cap
- RQI 1.7B
- CNTA 1.9B
- IPO Year
- RQI N/A
- CNTA 2021
- Fundamental
- Price
- RQI $12.16
- CNTA $18.05
- Analyst Decision
- RQI
- CNTA Strong Buy
- Analyst Count
- RQI 0
- CNTA 10
- Target Price
- RQI N/A
- CNTA $30.56
- AVG Volume (30 Days)
- RQI 432.6K
- CNTA 1.1M
- Earning Date
- RQI 01-01-0001
- CNTA 08-12-2025
- Dividend Yield
- RQI 8.20%
- CNTA N/A
- EPS Growth
- RQI N/A
- CNTA N/A
- EPS
- RQI N/A
- CNTA N/A
- Revenue
- RQI N/A
- CNTA $15,000,000.00
- Revenue This Year
- RQI N/A
- CNTA N/A
- Revenue Next Year
- RQI N/A
- CNTA N/A
- P/E Ratio
- RQI N/A
- CNTA N/A
- Revenue Growth
- RQI N/A
- CNTA 118.88
- 52 Week Low
- RQI $9.17
- CNTA $9.60
- 52 Week High
- RQI $12.64
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- RQI 40.70
- CNTA 68.40
- Support Level
- RQI $12.08
- CNTA $16.78
- Resistance Level
- RQI $12.42
- CNTA $17.37
- Average True Range (ATR)
- RQI 0.16
- CNTA 0.98
- MACD
- RQI -0.03
- CNTA 0.03
- Stochastic Oscillator
- RQI 23.81
- CNTA 98.04
About RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the Fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.